Fever and rash in a 3-year-old girl: Rocky mountain spotted fever

Cutis

Volumn 70, Issue 3, 2002, Pages 165-168

  Kaufmann, Julie M ^a   Zaenglein, Andrea L ^b   Kaul, Aditya ^c   Chang, Mary Wu ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE;

ARTICLE; CASE REPORT; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; FEVER; FOLLOW UP; HOSPITALIZATION; HUMAN; PRESCHOOL CHILD; RASH; RISK ASSESSMENT; ROCKY MOUNTAIN SPOTTED FEVER; TREATMENT OUTCOME;

CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; DRUG ADMINISTRATION SCHEDULE; EXANTHEMA; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; RISK ASSESSMENT; ROCKY MOUNTAIN SPOTTED FEVER; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036728289     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Thorner AR, Walker DH, Petri WA Jr. Rocky Mountain spotted fever. Clin Infect Dis. 1998;27:1353-1360.
2. Walker DH. Tick-transmitted infectious diseases in the United States. Annu Rev Public Health. 1998;19:237-269.
3. Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 1998. MMWR Morb Mortal Wkly Rep. 1998;47(53).
4. Abramson JS, Givner LB. Rocky Mountain spotted fever. Pediatr Infect Dis J. 1999;18:539-540.
5. Schaffner W. Rickettsial diseases. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, eds. Dermatology in General Medicine. 4th ed. New York, NY: McGraw-Hill; 1993:2500-2503.
6. Cale DF, McCarthy MW. Treatment of Rocky Mountain spotted fever in children. Ann Pharmacother. 1997;31:492-493.
7. Centers for Disease Control and Prevention. Rocky Mountain spotted fever. Available at: http://www.cdc.gov /ncidod/dvrd/rmsf. Accessed April 3, 2002.
8. Brown M, Hebert AA. Insect repellants: an overview. J Am Acad Dermatol. 1997;36:243-249.